⌘K

Cyclo Therapeutics, Inc. (CYTH)

$0.64 -0.73% $-0.00 Healthcare

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

Market cap

$18.42M

CEO

Mr. N. Scott Fine

Full time employees

9.00

Headquarters

Gainesville, FL

IPO Date

Feb 18, 2011

Price-to-earnings (PE) Ratio

-0.78

Earnings-per-share (EPS)

$-0.82

Cash ratio (TTM)

0.46

Current ratio (TTM)

1.01

Net profit margin (TTM)

-1,721.64%

PE ratio (TTM)

-1.70

PEG ratio (TTM)

-0.22

Price-to-book ratio (TTM)

53.89

Price-to-sales ratio (TTM)

29.21

Quick ratio (TTM)

0.47

Return on assets (TTM)

-270.71%

Return on equity (TTM)

-2,741.57%

Similar stocks (13)

Intra-Cellular Therapies, Inc.

ITCI

$75.26 -0.16% $-0.12

Neutral

Amneal Pharmaceuticals, Inc.

AMRX

$8.78 1.86% $0.16

Uptrend

Phibro Animal Health Corporation

PAHC

$21.53 -2.09% $-0.46

Uptrend

Ironwood Pharmaceuticals, Inc.

IRWD

$4.47 -2.19% $-0.10

Downtrend

Aquestive Therapeutics, Inc.

AQST

$4.96 2.48% $0.12

Uptrend

Alpha Teknova, Inc.

TKNO

$4.40 0.00% $0.00

Uptrend

Lifecore Biomedical, Inc.

LFCR

$5.09 -1.74% $-0.09

Downtrend

Assertio Holdings, Inc.

ASRT

$1.24 1.64% $0.02

Neutral

Silver Spike Investment Corp.

SSIC

$11.53 0.44% $0.05

Neutral

Eagle Pharmaceuticals, Inc.

EGRX

$4.23 -1.86% $-0.08

Downtrend

Guardion Health Sciences, Inc.

GHSI

$9.89 -0.20% $-0.02

Neutral

Agile Therapeutics, Inc.

AGRX

$1.51 0.00% $0.00

Uptrend

Petros Pharmaceuticals, Inc.

PTPI

$0.38 4.99% $0.02

Downtrend

ETF Exposure (6)

iShares Micro-Cap ETF

IWC

0.00345%

$122.64 -0.28% $-0.34

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.94 0.72% $0.96

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.72 0.18% $0.50

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.92 0.72% $0.96

Uptrend

Vanguard Extended Market Index Fund

VXF

$178.36 0.55% $0.97

Uptrend

Downtrend

Similar stocks (13)

Intra-Cellular Therapies, Inc.

ITCI

$75.26 -0.16% $-0.12

Neutral

Amneal Pharmaceuticals, Inc.

AMRX

$8.78 1.86% $0.16

Uptrend

Phibro Animal Health Corporation

PAHC

$21.53 -2.09% $-0.46

Uptrend

Ironwood Pharmaceuticals, Inc.

IRWD

$4.47 -2.19% $-0.10

Downtrend

Aquestive Therapeutics, Inc.

AQST

$4.96 2.48% $0.12

Uptrend

Alpha Teknova, Inc.

TKNO

$4.40 0.00% $0.00

Uptrend

Lifecore Biomedical, Inc.

LFCR

$5.09 -1.74% $-0.09

Downtrend

Assertio Holdings, Inc.

ASRT

$1.24 1.64% $0.02

Neutral

Silver Spike Investment Corp.

SSIC

$11.53 0.44% $0.05

Neutral

Eagle Pharmaceuticals, Inc.

EGRX

$4.23 -1.86% $-0.08

Downtrend

Guardion Health Sciences, Inc.

GHSI

$9.89 -0.20% $-0.02

Neutral

Agile Therapeutics, Inc.

AGRX

$1.51 0.00% $0.00

Uptrend

Petros Pharmaceuticals, Inc.

PTPI

$0.38 4.99% $0.02

Downtrend

ETF Exposure (6)

iShares Micro-Cap ETF

IWC

0.00345%

$122.64 -0.28% $-0.34

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.94 0.72% $0.96

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.72 0.18% $0.50

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.92 0.72% $0.96

Uptrend

Vanguard Extended Market Index Fund

VXF

$178.36 0.55% $0.97

Uptrend